Proto Labs (PRLB)
(Real Time Quote from BATS)
$28.45 USD
-0.68 (-2.33%)
Updated Sep 25, 2024 01:44 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 504 | 488 | 488 | 434 | 459 |
Cost Of Goods | 282 | 273 | 265 | 217 | 223 |
Gross Profit | 222 | 215 | 223 | 218 | 235 |
Selling & Adminstrative & Depr. & Amort Expenses | 194 | 313 | 182 | 158 | 155 |
Income After Depreciation & Amortization | 28 | -98 | 40 | 60 | 80 |
Non-Operating Income | 0 | 0 | 0 | 3 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 28 | -98 | 40 | 63 | 81 |
Income Taxes | 11 | 6 | 7 | 12 | 18 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 17 | -103 | 33 | 51 | 64 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 17 | -103 | 33 | 51 | 64 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 66 | -59 | 81 | 93 | 111 |
Depreciation & Amortization (Cash Flow) | 38 | 39 | 40 | 33 | 31 |
Income After Depreciation & Amortization | 28 | -98 | 40 | 60 | 80 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 26.22 | 27.41 | 27.65 | 26.90 | 27.05 |
Diluted EPS Before Non-Recurring Items | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 |
Diluted Net EPS (GAAP) | 0.66 | -3.77 | 1.21 | 1.89 | 2.35 |
Fiscal Year end for Proto Labs, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 125.63 | 127.89 | 125.05 | 130.71 | 122.27 |
Cost Of Goods | 69.09 | 70.42 | 69.24 | 71.42 | 69.14 |
Gross Profit | 56.55 | 57.47 | 55.81 | 59.28 | 53.12 |
SG&A, R&D, and Dept/Amort Expenses | 50.55 | 50.64 | 47.42 | 48.87 | 47.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 6.00 | 6.83 | 8.39 | 10.41 | 5.60 |
Non-Operating Income | 1.36 | 0.90 | 1.54 | 0.32 | -3.37 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 7.36 | 7.73 | 9.94 | 10.74 | 2.24 |
Income Taxes | 2.82 | 2.46 | 2.95 | 2.78 | 2.62 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 4.54 | 5.27 | 6.99 | 7.95 | -0.38 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 4.54 | 5.27 | 6.99 | 7.95 | -0.38 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 25.37 | 25.79 | 25.89 | 26.03 | 26.21 |
Diluted EPS Before Non-Recurring Items | 0.18 | 0.20 | 0.27 | 0.31 | -0.01 |
Diluted Net EPS (GAAP) | 0.18 | 0.20 | 0.26 | 0.31 | -0.01 |